NCT01404637

Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)

The Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic BPH

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: Male
• Age: 45 Years – 80 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the efficacy and safety of tamsulosin 0.4mg (Harnal® D. 0.2mg, 2T) with tamsulosin 0.2mg (Harnal® D 0.2mg, 1T) in patients with severe symptomatic benign prostatic hyperplasia as a first line therapy.

Conditions

• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	Tamsulosin 0.4mg	Treatment: tamsulosin 0.2mg (2T) /day Posology: two 0.2 mg tablet to be taken after an evening meal.
DRUG	Tamsulosin 0.2mg	tamsulosin 0.2mg (1T) /day Posology: one tablet to be taken after an evening meal.

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-07-01
• Completion: 2013-10-01
• First posted: 2011-07-28
• Last updated: 2011-08-02